Heme Oxygenase-1 as Crucial Biomarker for Detecting Oxidative Stress and Some Parameters in a Sample of Obese Patients with and without Diabetes
Abstract
Objective: Obesity is a significant contributor to various metabolic disorders, including type 2 diabetes (T2D), resulting in heightened oxidative stress. This study aims to examine the levels of heme oxygenase-1 (HO-1), their correlation with high-density lipoprotein (HDL) concentration, and their influence on the onset of T2D in obese individuals with diabetes. Materials and methods: The study comprised 150 samples categorized into 3 groups, with each group further subdivided into 2 subgroups: males and females aged 30 to 65 years. Samples were collected at AL-Kindy Teaching Hospital. All sample variables for fasting subjects in every group were assessed. The colorimetric approach was employed for biochemical assays, encompassing fasting blood sugar (FBS) and lipid profiles. Insulin, HO-1, and dipeptidyl peptidase-4 (DPP-4) levels were also quantified using ELISA. Subsequently, we employed statistical analysis to elucidate the results. Results: Compared to the obesity group, the HO-1 and HDL concentrations were higher in T2D with obesity [(18.0 ± 0.40), (39.86 ± 1.26) vs. (10.41 ± 0.74), (36.27 ± 0.85), with (ng/mL), (mg/dL), respectively]. The T2D with obesity group also showed higher insulin resistance compared to the obesity and control groups [(4.19 ± 0.874) vs. (1.21 ± 0.39), (0.74 ± 0.142)]. The diabetes with obesity male group had elevated HO-1 concentrations compared with the obesity male group, a result that also applied to females. Conclusions: The T2D with obesity group had higher concentrations of the HO-1 enzyme than the obesity group. We found a positive association between higher HDL concentrations and increased enzyme concentrations in the T2D with obesity group. This enzyme may serve as a biomarker to predict the development of diabetes or the onset of other metabolic diseases.
Keywords: obesitytype 2 diabetesheme oxygenase-1dipeptidyl peptidase-4oxidative stress
References
- Abdulrahman M, Elbakry S, Samy N, et al. Pregnancy outcome in a cohort of Egyptian women with rheumatoid arthritis. The Egyptian Rheumatologist. 2020; 42(2): 83–87.
- Mohammed AH, Nadr JH. Early complications associated with obesity following coronary artery bypass graft surgery. J Fac Med Baghdad. 2021; 63(4): 158–162.
- Zaid A, Al-Yassin HD. Correlation of Serum levels of Chromium, Copper, and Manganese with the Glucose levels in Type 2 Diabetes Mellitus in Iraq. Journal of the Faculty of Medicine Baghdad. 2024; 65(4).
- Wondmkun YT. Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes Metab Syndr Obes. 2020; 13: 3611–3616.
- Rahman MdS, Hossain KS, Das S, et al. Role of Insulin in Health and Disease: An Update. Int J Mol Sci. 2021; 22(12).
- Wang L, Tang J, Wang L, et al. Oxidative stress in oocyte aging and female reproduction. J Cell Physiol. 2021; 236(12): 7966–7983.
- Yaribeygi H, Sathyapalan T, Atkin SL, et al. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2020; 2020: 8609213.
- Wegiel B, Nemeth Z, Correa-Costa M, et al. Heme oxygenase-1: a metabolic nike. Antioxid Redox Signal. 2014; 20(11): 1709–1722.
- Mohammed NA, Khaleel FM. Studying the Role of Heme Oxygenase-1 in Obese Patients. Baghdad Science Journal. 2024; 21(7): 8406.
- Yachie A. Heme Oxygenase-1 Deficiency and Oxidative Stress: A Review of 9 Independent Human Cases and Animal Models. Int J Mol Sci. 2021; 22(4).
- Shao DW, Zhao LJ, Sun JF. Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM). Eur J Med Chem. 2024; 272: 116464.
- Huang J, Liu X, Wei Y, et al. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease. Front Immunol. 2022; 13: 830863.
- Jaid H, Khaleel F, Salman I, et al. Estimation of Apelin Levels in Iraqi Patients with Type II Diabetic Peripheral Neuropathy. Baghdad Science Journal. 2023; 20(5): 1684.
- Klein S, Gastaldelli A, Yki-Järvinen H, et al. Why does obesity cause diabetes? Cell Metab. 2022; 34(1): 11–20.
- Roche MM, Wang PP. Factors associated with a diabetes diagnosis and late diabetes diagnosis for males and females. J Clin Transl Endocrinol. 2014; 1(3): 77–84.
- Censin JC, Peters SAE, Bovijn J, et al. Causal relationships between obesity and the leading causes of death in women and men. PLoS Genet. 2019; 15(10): e1008405.
- Mirzaei M, Khajeh M. Comparison of anthropometric indices (body mass index, waist circumference, waist to hip ratio and waist to height ratio) in predicting risk of type II diabetes in the population of Yazd, Iran. Diabetes Metab Syndr. 2018; 12(5): 677–682.
- Otto T, Diesing J, Borchert J, et al. Age-dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data. Diabetes Obes Metab. 2023; 25(3): 767–775.
- Abed BA, Farhan LO, Dawood AS. Relationship between serum Nesfatin-1, Adiponectin, Resistin Concentration, and Obesity with Type 2 Diabetes Mellitus. Baghdad Science Journal. 2024; 21(1): 117–123.
- Wondmkun YT. Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes Metab Syndr Obes. 2020; 13: 3611–3616.
- Yang Y, Zhang Y, Wang J, et al. Sex Differences in the Association of HOMA-IR Index and BDNF in Han Chinese Patients With Chronic Schizophrenia. Front Psychiatry. 2021; 12: 656230.
- Tramunt B, Smati S, Grandgeorge N, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020; 63(3): 453–461.
- Aljabri K, Bokhari S, Akl A. The relation between overweight, obesity and plasma lipids in Saudi adults with type 2 diabetes. Journal of Health Specialties. 2016; 4(2): 140.
- Jaid HK, Khaleel FM, Salman IN, et al. Evaluation of Insulin Resistance and Glutathione-S-transferase in Iraqi Patients with Type 2 Diabetes Mellitus and Diabetic Peripheral Neuropathy. Ibn AL-Haitham Journal For Pure and Applied Sciences. 2022; 35(4): 194–205.
- Abed BA, Hamid GS. Evaluation of Lipocalin-2 and Vaspin Levels in In Iraqi Women with Type 2 Diabetes Mellitus. Iraqi J Sci. 2022; 63(11): 4650–4658.
- Bao W, Song F, Li X, et al. Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One. 2010; 5(8): e12371.
- Andrews M, Leiva E, Arredondo-Olguín M. Short repeats in the heme oxygenase 1 gene promoter is associated with increased levels of inflammation, ferritin and higher risk of type-2 diabetes mellitus. J Trace Elem Med Biol. 2016; 37: 25–30.
- Song F, Li X, Zhang M, et al. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Am J Epidemiol. 2009; 170(6): 747–756.
- McClung JA, Levy L, Garcia V, et al. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications. Pharmacol Ther. 2022; 231: 107975.
- Chekol GZ, Mengistu D, Tadesse AW. Is the Duration of Diabetes Diseases Positively Associated With Knowledge About Diabetic Complications? Knowledge of Diabetes Mellitus Complications and Associated Factors Among Type-2 Diabetic Patients in Public Hospitals of Addis Ababa, 2020. Front Public Health. 2021; 9: 812586.
- Sarkar J, Nargis T, Tantia Om, et al. Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients. Front Endocrinol (Lausanne). 2019; 10: 505.
- Deacon CF. Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes. Front Endocrinol (Lausanne). 2019; 10: 80.
- Bae EJu. DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control. Arch Pharm Res. 2016; 39(8): 1114–1128.
- Tahara N, Yamagishi Si, Takeuchi M, et al. Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans. Clin Biochem. 2013; 46(4-5): 300–303.